Iowa’s 4.5-Gram THC Cap

Last verified: April 2026

What the Cap Actually Is

Iowa’s defining unique feature is the 4.5-gram total THC per rolling 90-day period purchase and possession limit, codified through 641 IAC 154 implementing Iowa Code Chapter 124E and House File 2589 (2020). HF 2589 raised the prior, lower limit and replaced an earlier 3% per-product THC concentration ceiling with this patient-side mass cap.

This is not a product-weight cap. Every other medical cannabis state that imposes patient purchase limits expresses them in product weight: Pennsylvania allows a 30-day supply of product; Florida allows 2.5 ounces of flower per 35 days; Massachusetts and Oregon use 2.5-ounce / 14-day windows. Iowa is unique in capping the active-ingredient mass itself.

Iowa Code §124E and 641 IAC 154 limit a registered patient to a 90-day rolling total of 4.5 grams of THC, enforced at point of sale by the dispensary tracking system. The cap was raised to 4.5 grams from a lower prior limit by HF 2589 (2020).

Iowa Code Chapter 124E; 641 IAC 154; HF 2589 (2020)

What 4.5 Grams of THC Actually Buys

The math is unforgiving:

• A typical 1-gram vape cartridge in Iowa contains 700–800 mg (0.7–0.8 g) of THC.
• 4.5 g THC ÷ 0.75 g per cart ≈ 6 vape cartridges per 90 days — about two cartridges per month, or one every two weeks.
• A 30 mL tincture at 30 mg THC per mL contains 900 mg per bottle. 4.5 g = five bottles per 90 days.
• 10 mg THC capsules: 4,500 mg ÷ 10 mg = 450 capsules per 90 days, or 5 per day.

For a chronic-pain patient consuming 30–50 mg THC per day — a clinically common dose for opioid-sparing pain management — 4.5 g lasts only 30 to 50 days, well short of the 90-day window. For a cancer patient using THC for nausea and appetite during chemotherapy, the cap is often grossly inadequate. For high-tolerance patients with PTSD or severe MS spasticity, 4.5 g per 90 days is barely a baseline dose.

Pricing Math: $65–$120 per Gram of THC

Iowa medical cannabis pricing is among the highest in the country precisely because of supply-side restrictions (two manufacturers, five dispensaries, no economies of scale). A 1-gram vape cartridge averages around $65, with live-resin or full-spectrum carts running $85–$136. Effective price per gram of pure THC equivalent runs $65–$120.

A patient purchasing the full 4.5 g over 90 days therefore spends roughly $300–$540 every 90 days — or $1,200–$2,160 per year. None of it is reimbursed by health insurance, Medicare, Medicaid, or workers’ compensation under Iowa Code §124E.22.

Comparison to Other States

How Iowa’s mass-based cap compares to neighboring product-weight caps:

The Waiver Process

Iowa Code Chapter 124E and 641 IAC 154 permit two narrow exceptions to the 4.5-g cap:

1. Terminal-illness exception. A patient with a terminal medical condition and a probable life expectancy of one year or less may submit a THC waiver with their initial application. The certifying healthcare practitioner specifies an appropriate higher amount.
2. Established-patient exception. A patient already enrolled in the program whose original certifying practitioner determines that 4.5 g is insufficient may complete the “Waiver for 90-Day THC Purchase Limit” form. The waiver must come from the original certifying practitioner, not a different provider.

Per the Iowa Medical Cannabidiol Board’s 2024 Annual Report, only a fraction of active patients hold THC waivers, with the highest waiver rates concentrated among chronic-pain and cancer patients.

Pharmacist Consultation at Point of Sale

Iowa Code §124E.9 and HF 2589 require every dispensary to employ a pharmacist or pharmacy technician. Patients consult with the pharmacist on dosing, drug interactions, and product selection — a feature that distinguishes Iowa’s program from typical “budtender” medical retail. Dispensary staff scan the patient’s card and verify the 90-day rolling THC purchase total in the secure sales-and-inventory tracking system. The system enforces the 4.5-g cap automatically; sales above the cap (or above the patient’s waivered amount) are blocked at point of sale.

Patient Frustration and Documented Undertreatment

Patient advocacy groups — including Iowans for Medical Marijuana (founded by Carl Olsen in 1990), Iowa NORML, and informal coalitions like Quad Cities Patients United — have repeatedly testified before the Medical Cannabidiol Board that the 4.5-g cap forces undertreatment and drives patients to the illicit market or across state lines. At the May 16, 2025 board meeting, Bud & Mary’s Iowa Market President Kevin O’Connor described “Iowa’s 18,000 patients and caregivers” and expressed disappointment that vaporizable-flower expansion failed in the 2025 session.

Patient testimony at recent board meetings has repeatedly highlighted that 4.5 g is “insufficient for chronic pain management” and that Iowa’s three legalized neighbors offer products without comparable caps. Senate File 599 (2022) added autism and severe pain expansion but did not raise the cap.

Explore More